Page 1295 - Williams Hematology ( PDFDrive )

1270 Part IX: Lymphocytes and Plasma Cells Chapter 82: Mononucleosis Syndromes 1271

REFERENCES 35. Pichler R, Berg J, Hengtschlager A, et al: Recurrent infectious mononucleosis caused by
Epstein-Barr virus with persistent splenomegaly. Mil Med 166:733, 2001.
1. Pfeiffer E: Drüsenfieber. Jahrbuch für Kinderheilkunde 23:257, 1885. 36. Sumaya CV, Ench Y: Epstein-Barr virus infectious mononucleosis. I. Clinical and gen-
2. Sprunt TP, Evans FA: Mononucleosis in reaction to acute infections (“infectious mono- eral laboratory findings. Pediatrics 75:1003, 1985.
nucleosis”). Johns Hopkins Bull 31:410, 1920. 37. Sumaya CV, Ench Y: Epstein-Barr virus infectious mononucleosis. II. Heterophil anti-
3. Paul JR, Bunnell WW: The presence of heterophile antibodies in infectious mononucle- body and viral-specific responses. Pediatrics 75:1011, 1985.
osis. Am J Med Sci 183:91, 1932. 38. Fleisher G, Henle W, Henle G, et al: Primary infection with Epstein-Barr virus in the
4. Davidson I, Walker PH: The nature of the heterophile antibodies in infectious mononu- United States: Clinical and serologic observations. J Infect Dis 139:553, 1979.
cleosis. Am J Clin Pathol 5:455, 1935. 39. Hickey SM, Strasburger VC: What every pediatrician should know about infectious
5. Henle G, Henle W, Diehl V: Relation of Burkitt’s tumor associated herpes type virus to mononucleosis in adolescents. Pediatr Clin North Am 44:1541, 1997.
infectious mononucleosis. Proc Natl Acad Sci U S A 59:94, 1968. 40. Axelrod P, Finestone AJ: Infectious mononucleosis in older adults. Am Fam Physician
6. Niederman JC, McCollum RW, Henle G, et al: Infectious mononucleosis: Clinical man- 42:1599, 1990.
ifestations in relation to EB virus antibodies. JAMA 203:205, 1968. 41. Hurwitz CA, Henle W, Henle G, et al: Infectious mononucleosis in patients aged 40
7. Evans AS, Niederman JC, McCollum RW: Seroepidemiologic studies of infectious to 72 years: Report of 27 cases, including 3 without heterophile-antibody responses.
mononucleosis with EB virus. N Engl J Med 279:1121, 1968. Medicine (Baltimore) 62:256, 1983.
8. Sawyer RN, Evans AS, Niederman JC, et al: Prospective studies of a group of Yale 42. Karajannis MA, Hummel M, Anagnostopoulos I, Stein H: Strict lymphotropism of
University freshman: I. Occurrence of infectious mononucleosis. J Infect Dis 123:263 Epstein-Barr virus during acute infectious mononucleosis in non-immunocompro-
1971. mised individuals. Blood 89:2856, 1997.
9. Infectious mononucleosis and its relationship to EB virus antibody. A joint investiga- 43. Yefenof E, Bakacs T, Einhorn L, et al: Epstein-Barr virus (EBV) receptors, complement
tion by university health physicians and P.H.L.S. laboratories. Br Med J 4:643, 1971. receptors and EBV infectibility of different lymphocyte fractions of human peripheral
10. Hoagland RJ: The clinical manifestations of infectious mononucleosis: A report of 200 blood: I. Complement receptor distribution and complement binding by separated
cases. Am J Med Sci 240:55, 1960. lymphocyte subpopulations. Cell Immunol 35:34, 1978.
11. Hoagland RJ: The incubation period of infectious mononucleosis. Am J Public Health 44. Drebber U, Kasper HU, Krupacz J: et al: The role of Epstein-Barr virus in acute and
54:1699, 1964. chronic hepatitis. J Hepatol 44:879, 2006.
12. Tanner J, Weis J, Fearon D, et al: Epstein-Barr virus gp350/220 binding to the B lympho- 45. Levitskaya K, Coram M, Levitsky V, et al: Inhibition of antigen processing by the inter-
cyte C3d receptor mediates adsorption, capping, and endocytosis. Cell 50:203, 1987. nal repeat region of the Epstein-Barr Nuclear antigen-1. Nature 375:685, 1995.
13. Söderberg-Nauclér C, Fish KN, Nelson JA: Reactivation of latent human cytomegalovi- 46. Renn CN, Straff W, Dorfmuller A, et al: Amoxicillin-induced exanthema in young
rus by allogeneic stimulation of blood cells from healthy donors. Cell 91:119, 1997. adults with infectious mononucleosis: Demonstration of drug-specific lymphocyte
14. Tomkinson BE, Wagner DK, Nelson DL, Sullivan JL: Activated lymphocytes during reactivity. Br J Dermatol 147:1166, 2002.
acute Epstein-Barr virus infection. J Immunol 139:3802, 1987. 47. Haverkos HW, Amsel Z, Drotman DP: Adverse virus-drug interactions. Rev Infect Dis
15. Lajo A, Borque C, Del Castillo F, Martin-Ancel A: Mononucleosis caused by Epstein- 13:697, 1991.
Barr virus and Cytomegalovirus in children: A comparative study of 124 cases. Pediatr 48. Linderholm M, Boman J, Juto P, Linde A: Comparative evaluation of nine kits for rapid
Infect Dis J 13:56, 1994. diagnosis of infectious mononucleosis and Epstein-Barr virus-specific serology. J Clin
16. Porter DP, Wimberly I, Benyesh-Melnick M: Prevalence of antibodies to EB virus and Microbiol 32:259, 1994.
other herpes viruses. JAMA 209:1675, 1969. 49. Rea TD, Ashley TL, Russo JE, Buchwald DS: A systematic study of Epstein-Barr virus
17. Ross SA, Arora N, Novak Z, et al: Cytomegalovirus reinfections in healthy seroimmune serologic assays following acute infection. Am J Clin Pathol 117:156, 2002.
women. J Infect Dis 201:386, 2010. 50. Pitetti RD, Laus S, Wadowsky RM: Clinical evaluation of a quantitative real time poly-
18. Schmader KE, van der Horst CM, Klotman ME: Epstein-Barr virus and the elderly host. merase chain reaction assay for diagnosis of primary Epstein-Barr virus infection in
Rev Infect Dis 11:64, 1989. children. Pediatr Infect Dis J 22:736, 2003.
19. Fleisher G, Bologonese R: Epstein-Barr virus infections in pregnancy: A prospective 51. Hudnall SD, Patel JU, Schwab H, Martinez J: Comparative immunophenotypic features
study. J Pediatr 104:374, 1984. of EBV-positive and EBV-negative atypical lymphocytosis. Cytometry 55B:22, 2003.
20. Istas AS, Demmler GJ, Dobbins JG, Stewart JA: Surveillance for congenital cytomeg- 52. Matsukawa Y, Okano M, Ishikawa N, Imasi S: Severe thrombocytopenic purpura asso-
alovirus disease: A report from the National Congenital Cytomegalovirus Disease ciated with primary Epstein-Barr virus infection. J Infect 29:107, 1994.
Registry. Clin Infect Dis 20:665, 1995. 53. Whitelaw F, Brook MG, Kennedy N, Weir WR: Haemolytic anemia complicating
21. Senechal B, Boruchov AM, Reagan JL, et al: Infection of mature monocyte-derived den- Epstein-Barr virus infection. Br J Clin Pract 49:212, 1995.
dritic cells with human cytomegalovirus inhibits stimulation of T-cell proliferation via 54. Lazarus KH, Baehner RL: Aplastic anemia complicating infectious mononucleosis: A
the release of soluble CD83. Blood 103:420, 2004. case report and review of the literature. Pediatrics 67:907, 1981.
22. Hussein K, Tiede C, Maecker-Kolhoff B, Kreipe H: Posttransplant lymphoproliferative 55. Auvin S, Dalle JH, Ganga-Zandzou PS, Ythier H: Is agranulocytosis following infec-
disorder in pediatric patients. Pathobiology 80:289, 2013. tious mononucleosis caused by autoimmunity? Pediatr Hematol Oncol 20:611, 2003.
23. Hochberg D, Souza T, Catalina M, et al: Acute infection with Epstein-Barr virus targets 56. Tanaka M, Kamijo T, Koike T, et al: Specific auto antibodies to platelet glycoprotein
and overwhelms peripheral memory B-cell compartment with resting, latently infected in Epstein-Barr virus-associated immune thrombocytopenia. Int J Hematol 78:168,
cells. J Virol 78:5194, 2004. 2003.
24. Hadinoto V, Shapiro M, Greenough TC, et al: On the dynamics of acute EBV infection 57. Evans AS: Infectious mononucleosis and related syndromes. Am J Med Sci 276:325,
and the pathogenesis of infectious mononucleosis. Blood 111:1420, 2008. 1978.
25. McAulay KA, Higgins CD, Macsween KF, et al: HLA class I polymorphisms are associ- 58. Jones JF: A perspective on Epstein-Barr virus diseases. Adv Pediatr 36:307, 1989.
ated with development of infectious mononucleosis upon primary EBV infection. J Clin 59. Bhaskaran J, Harkness DR: Hereditary spherocytosis unmasked by infectious mononu-
Invest 117:3042, 2007. cleosis with autoimmune hemolytic anemia. J Fla Med Assoc 67:483, 1980.
26. Vollmer-Conner U, Piraino B, Cameron B, et al: Cytokine polymorphisms have a syn- 60. Taylor JJ: Haemolysis in infectious mononucleosis: Inapparent congenital spherocyto-
ergistic effect on the acute sickness response to infection. Clin Infect Dis 47:1418, 2008. sis. Br Med J 4:525, 1973.
27. Scherrenburg J, Piriou ER, Nanlohy NM, van Baarle D: Detailed analysis of Epstein- 61. Asgari MM, Begos DG: Spontaneous splenic rupture in infectious mononucleosis: A
Barr virus specific CD4+ and CD8+ T cell response during infectious mononucleosis. review. Yale J Biol Med 70:175, 1997.
Clin Exp Immunol 153:231, 2008. 62. Kinderknecht JJ: Infectious mononucleosis and the spleen. Curr Sports Med Rep 1:116,
28. Balfour HH Jr, Odumade OA, Schmeling DO, et al: Behavioral, virologic, and immu- 2002.
nologic factors associated with acquisition and severity of primary Epstein-Barr virus 63. Fujimoto H, Asaoka K, Imaaizumi T, et al: Epstein-Barr virus infections of the central
infection in university students. J Infect Dis 207:80, 2013. nervous system. Intern Med 42:33, 2003.
29. Grotto I, Mimouni D, Huerta M, et al: Clinical and laboratory presentation of EBV 64. Connelly KP, DeWitt LD: Neurologic complications of infectious mononucleosis.
positive infectious mononucleosis in young adults. Epidemiol Infect 131:683, 2003. Pediatr Neurol 10:181, 1994.
30. Macallan DC, Wallace DL, Irvine AJ, et al: Rapid turnover of T cells in acute infectious 65. Jacobs BC, Rothbarth PH, van der Meche, et al: The spectrum of antecedent infections
mononucleosis. Eur J Immunol 33:2655, 2003. in Guillain-Barré syndrome. Neurology 51:1110, 1998.
31. Williams H, Macsween K, McAulay K, et al: Analysis of immune activation and clinical 66. Hughes RA, Hadden RD, Gregson NA, Smith KJ: Pathogenesis of Guillain-Barré syn-
events in acute infectious mononucleosis. J Infect Dis 190:63, 2004. drome. J Neuroimmunol 100:74, 1999.
32. Kusuhara K, Takabayashi A, Ueda K, et al: Breast milk is not a significant source of early 67. Ang CW, Lang BC, Laman JD: The Guillain-Barré syndrome, a true case of molecular
Epstein-Barr virus or human herpes 6 infections in infants. A sero-epidemiologic study mimicry. Trends Immunol 25:561, 2004.
in two 2 areas of human T cell lymphotropic virus type 1 in Japan. Microbiol Immunol 68. Cameron B, Galbraith S, Zhang Y, et al: Gene expression correlates of post fatigue syn-
41:309, 1997. drome after infectious mononucleosis. J Infect Dis 196:56, 2007.
33. Sixbey JW, Shirley P, Chesney PJ, et al: Detection of a second widespread strain of 69. Lerner AM, Benquai SM, Deeter RG, Fitzgerald JT: Valacyclovir treatment in Epstein-
Epstein-Barr virus. Lancet 2:76, 1989. Barr virus subset of chronic fatigue syndrome-36 month follow up. In Vivo 21:707,
34. Yao QY, Croom-Carter DSG, Tierney RJ, et al: Epidemiology of infection with Epstein- 2007.
Barr virus types 1 and 2: Lessons from the study of a T cell immunocompromised 70. Thacker EL, Mirzaei F, Ascherio A: Infectious mononucleosis and risk of multiple scle-
hemophiliac cohort. J Virol 72:4352, 1998. rosis: A meta-analysis. Ann Neurol 59:499, 2006.

Kaushansky_chapter 82_p1261-1272.indd 1270 9/18/15 10:06 AM